Literature DB >> 26997538

Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Manoela Mota1, Bubu A Banini2, Sophie C Cazanave2, Arun J Sanyal3.   

Abstract

The exposure of hepatocytes to high concentrations of lipids and carbohydrates and the ensuing hepatocellular injury are termed lipotoxicity and glucotoxicity, respectively. A common denominator is metabolic derangement, especially in regards to intracellular energy homeostasis, which is brought on by glucose intolerance and insulin resistance in tissues. In this review, we highlight the lipids and carbohydrates that provoke hepatocyte injury and the mechanisms involved in lipotoxicity and glucotoxicity, including endoplasmic reticulum stress, oxidative stress and mitochondrial impairment. Through upregulation of proteins involved in various pathways including PKR-like ER kinase (PERK), CCAAT/enhancer-binding homologous protein (CHOP), c-Jun NH2-terminal kinase-1 (JNK), Bcl-2 interacting mediator (BIM), p53 upregulated modulator of apoptosis (PUMA), and eventually caspases, hepatocytes in lipotoxic states ultimately undergo apoptosis. The protective role of certain lipids and possible targets for pharmacological therapy are explored. Finally, we discuss the role of high fructose and glucose diets in contributing to organelle impairment and poor glucose transport mechanisms, which perpetuate hyperglycemia and hyperlipidemia by shunting of excess carbohydrates into lipogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHOP; JNK; Lipid; NASH; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26997538      PMCID: PMC4931958          DOI: 10.1016/j.metabol.2016.02.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  123 in total

1.  Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.

Authors:  Lay T Gan; Derrick M Van Rooyen; Mark E Koina; Robert S McCuskey; Narcissus C Teoh; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2014-07-24       Impact factor: 25.083

Review 2.  Interaction domains of p62: a bridge between p62 and selective autophagy.

Authors:  Xiaolong Lin; Shuang Li; Yue Zhao; Xiaofeng Ma; Kai Zhang; Xinglan He; Zuo Wang
Journal:  DNA Cell Biol       Date:  2013-03-26       Impact factor: 3.311

Review 3.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

4.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

5.  Standard short-term diet ameliorates the lipid profile altered by a fructose-rich diet in rats.

Authors:  L T Cambri; A C Ghezzi; G Arsa; J D Botezelli; M A R de Mello
Journal:  J Dev Orig Health Dis       Date:  2015-04-08       Impact factor: 2.401

Review 6.  Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.

Authors:  J Aubert; K Begriche; L Knockaert; M A Robin; B Fromenty
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-06-12       Impact factor: 2.947

7.  Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet.

Authors:  Xiaojun Liu; Yong Gao; Meixia Li; Chao Geng; Haifeng Xu; Yaoguo Yang; Yongjun Guo; Tao Jiao; Fude Fang; Yongsheng Chang
Journal:  J Hepatol       Date:  2015-05-27       Impact factor: 25.083

8.  Ceramides and glucosylceramides are independent antagonists of insulin signaling.

Authors:  Jose A Chavez; M Mobin Siddique; Siew Tein Wang; Jianhong Ching; James A Shayman; Scott A Summers
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

9.  Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.

Authors:  Lee-Won Chong; Yi-Chao Hsu; Ting-Fang Lee; Yun Lin; Yung-Tsung Chiu; Kuo-Ching Yang; Jaw-Ching Wu; Yi-Tsau Huang
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

10.  Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

Authors:  Stanley M H Chan; Ruo-Qiong Sun; Xiao-Yi Zeng; Zi-Heng Choong; Hao Wang; Matthew J Watt; Ji-Ming Ye
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

View more
  127 in total

1.  Leaves of Lippia triphylla improve hepatic lipid metabolism via activating AMPK to regulate lipid synthesis and degradation.

Authors:  Yi Zhang; Mengyang Liu; Qian Chen; Tingting Wang; Haiyang Yu; Jingqi Xu; Tao Wang
Journal:  J Nat Med       Date:  2019-05-18       Impact factor: 2.343

Review 2.  Adipose Tissue Composition in Obesity and After Bariatric Surgery.

Authors:  Gian Franco Adami; Federico Carbone; Fabrizio Montecucco; Giovanni Camerini; Renzo Cordera
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 3.  Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: focus on adipose tissue, liver, and pancreas.

Authors:  Aline Fernandes-da-Silva; Carolline Santos Miranda; Daiana Araujo Santana-Oliveira; Brenda Oliveira-Cordeiro; Camilla Rangel-Azevedo; Flávia Maria Silva-Veiga; Fabiane Ferreira Martins; Vanessa Souza-Mello
Journal:  Eur J Nutr       Date:  2021-03-19       Impact factor: 5.614

4.  Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.

Authors:  Bubu A Banini; Sophie C Cazanave; Katherine P Yates; Amon Asgharpour; Robert Vincent; Faridoddin Mirshahi; Peter Le; Melissa J Contos; James Tonascia; Naga P Chalasani; Kris V Kowdley; Arthur J McCullough; Cynthia A Behling; Jeffrey B Schwimmer; Joel E Lavine; Arun J Sanyal
Journal:  J Clin Gastroenterol       Date:  2019 Nov/Dec       Impact factor: 3.062

Review 5.  G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.

Authors:  Geetanjali Sharma; Eric R Prossnitz
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.

Authors:  Alan N Hunt; Anagha Malur; Tual Monfort; Pavlos Lagoudakis; Sumeet Mahajan; Anthony D Postle; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

Review 7.  Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis.

Authors:  Abdul M Oseini; Banumathi K Cole; Danny Issa; Ryan E Feaver; Arun J Sanyal
Journal:  Hepatol Int       Date:  2018-01-03       Impact factor: 6.047

8.  Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol.

Authors:  Yanjing Guo; Meng Zhao; Tao Bo; Shizhan Ma; Zhongshang Yuan; Wenbin Chen; Zhao He; Xu Hou; Jun Liu; Zhenhai Zhang; Qiang Zhu; Qiangxiu Wang; Xiaoyan Lin; Zhongli Yang; Min Cui; Lu Liu; Yujie Li; Chunxiao Yu; Xiaoyi Qi; Qian Wang; Haiqing Zhang; Qingbo Guan; Lifang Zhao; Shimeng Xuan; Huili Yan; Yanliang Lin; Li Wang; Qihang Li; Yongfeng Song; Ling Gao; Jiajun Zhao
Journal:  Cell Res       Date:  2018-12-17       Impact factor: 25.617

Review 9.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

10.  Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.

Authors:  Mojtaba Malek; Mohammad E Khamseh; Haleh Chehrehgosha; Sohrab Nobarani; Fariba Alaei-Shahmiri
Journal:  Endocrine       Date:  2021-08-05       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.